|
Originally published In Press as doi:10.1074/jbc.M111604200 on February 20, 2002
J. Biol. Chem., Vol. 277, Issue 19, 17179-17187, May 10, 2002
Transferrin Receptor-dependent Iron Uptake Is
Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells
ROLE OF OXIDANT-INDUCED IRON SIGNALING IN APOPTOSIS*
Srigiridhar
Kotamraju ,
Christopher R.
Chitambar§,
Shasi V.
Kalivendi ,
Joy
Joseph , and
B.
Kalyanaraman ¶
From the Biophysics Research Institute and Free
Radical Research Center and the § Division of Neoplastic
Diseases, Medical College of Wisconsin,
Milwaukee, Wisconsin 53226
In the past, investigators have successfully used
iron chelators to mitigate the cardiotoxicity of doxorubicin (DOX), a
widely used anticancer drug that induces reactive oxygen species (ROS), oxidative damage, and apoptosis. Although intracellular iron plays a critical role in initiating DOX-induced apoptosis, the molecular mechanism(s) that link iron, ROS, and apoptosis are still unknown. In
this study, we demonstrate that apoptosis results from the exposure of
bovine aortic endothelial cells to DOX and that the apoptotic cell
death is accompanied by a significant increase in cellular iron
(55Fe) uptake and activation of iron regulatory
protein-1. Furthermore, DOX-induced iron uptake was shown to be
mediated by the transferrin receptor (TfR)-dependent
mechanism. Treatment with the anti-TfR antibody (IgA class)
dramatically inhibited DOX-induced apoptosis, iron uptake, and
intracellular oxidant formation as measured by fluorescence using
dichlorodihydrofluorescein. Treatment with cell-permeable iron
chelators and ROS scavengers inhibited DOX-induced cellular
55Fe uptake, ROS formation, and apoptosis. Based on these
findings, we conclude that DOX-induced iron signaling is regulated by
the cell surface TfR expression, intracellular oxidant levels, and iron
regulatory proteins. The implications of TfR-dependent iron transport in oxidant-induced apoptosis in endothelial cells are discussed.
*
This work was supported by National Institutes of Health
Grants RR01008 and CA77822.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Biophysics
Research Inst., Medical College of Wisconsin, 8701 Watertown
Plank Rd., Milwaukee, WI 53226. Tel.: 414-456-4035;
Fax: 414-156-6512; E-mail: balarama@mcw.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Chiba, M. Tokuhara, E. H. Morita, and S. Abe
TTP at Ser245 Phosphorylation by AKT is Required for Binding to 14-3-3
J. Biochem.,
March 1, 2009;
145(3):
403 - 409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xu, R. Sutak, and D. R. Richardson
Iron Chelation by Clinically Relevant Anthracyclines: Alteration in Expression of Iron-Regulated Genes and Atypical Changes in Intracellular Iron Distribution and Trafficking
Mol. Pharmacol.,
March 1, 2008;
73(3):
833 - 844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Turakhia, C. D. Venkatakrishnan, K. Dunsmore, H. Wong, P. Kuppusamy, J. L. Zweier, and G. Ilangovan
Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H3111 - H3121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kotamraju, C. L. Willams, and B. Kalyanaraman
Statin-Induced Breast Cancer Cell Death: Role of Inducible Nitric Oxide and Arginase-Dependent Pathways
Cancer Res.,
August 1, 2007;
67(15):
7386 - 7394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Neilan, S. L. Blake, F. Ichinose, M. J. Raher, E. S. Buys, D. S. Jassal, E. Furutani, T. M. Perez-Sanz, A. Graveline, S. P. Janssens, et al.
Disruption of Nitric Oxide Synthase 3 Protects Against the Cardiac Injury, Dysfunction, and Mortality Induced by Doxorubicin
Circulation,
July 31, 2007;
116(5):
506 - 514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Andriopoulos, S. Hegedusch, J. Mangin, H.-D. Riedel, U. Hebling, J. Wang, K. Pantopoulos, and S. Mueller
Sustained Hydrogen Peroxide Induces Iron Uptake by Transferrin Receptor-1 Independent of the Iron Regulatory Protein/Iron-responsive Element Network
J. Biol. Chem.,
July 13, 2007;
282(28):
20301 - 20308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, P. Jungsuwadee, M. Vore, D. A. Butterfield, and D. K. St. Clair
Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues
Mol. Interv.,
June 1, 2007;
7(3):
147 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Neilan, D. S. Jassal, M. F. Scully, G. Chen, C. Deflandre, H. McAllister, E. Kay, S. C. Austin, E. F. Halpern, J. H. Harmey, et al.
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression
Eur. Heart J.,
May 2, 2006;
27(10):
1251 - 1256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Salvatorelli, S. Guarnieri, P. Menna, G. Liberi, A. M. Calafiore, M. A. Mariggio, A. Mordente, L. Gianni, and G. Minotti
Defective One- or Two-electron Reduction of the Anticancer Anthracycline Epirubicin in Human Heart: RELATIVE IMPORTANCE OF VESICULAR SEQUESTRATION AND IMPAIRED EFFICIENCY OF ELECTRON ADDITION
J. Biol. Chem.,
April 21, 2006;
281(16):
10990 - 11001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nanami, T. Ookawara, Y. Otaki, K. Ito, R. Moriguchi, K. Miyagawa, Y. Hasuike, M. Izumi, H. Eguchi, K. Suzuki, et al.
Tumor Necrosis Factor-{alpha}-Induced Iron Sequestration and Oxidative Stress in Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2495 - 2501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hose, G. Kaur, E. A. Sausville, and A. Monks
Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation
Clin. Cancer Res.,
September 1, 2005;
11(17):
6370 - 6381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Moura, M. Arcos-Fajardo, A. Gdoura, V. Leroy, C. Sadaka, N. Mahlaoui, Y. Lepelletier, F. Vrtovsnik, E. Haddad, M. Benhamou, et al.
Engagement of Transferrin Receptor by Polymeric IgA1: Evidence for a Positive Feedback Loop Involving Increased Receptor Expression and Mesangial Cell Proliferation in IgA Nephropathy
J. Am. Soc. Nephrol.,
September 1, 2005;
16(9):
2667 - 2676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Xie, N. Zhang, H. Zhou, J. Li, Q. Li, T. Zarubin, S.-C. Lin, and J. Han
Distinct Roles of Basal Steady-State and Induced H-Ferritin in Tumor Necrosis Factor-Induced Death in L929 Cells
Mol. Cell. Biol.,
August 1, 2005;
25(15):
6673 - 6681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xu, H. L. Persson, and D. R. Richardson
Molecular Pharmacology of the Interaction of Anthracyclines with Iron
Mol. Pharmacol.,
August 1, 2005;
68(2):
261 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dhanasekaran, S. Kotamraju, S. V. Kalivendi, T. Matsunaga, T. Shang, A. Keszler, J. Joseph, and B. Kalyanaraman
Supplementation of Endothelial Cells with Mitochondria-targeted Antioxidants Inhibit Peroxide-induced Mitochondrial Iron Uptake, Oxidative Damage, and Apoptosis
J. Biol. Chem.,
September 3, 2004;
279(36):
37575 - 37587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsunaga, S. Kotamraju, S. V. Kalivendi, A. Dhanasekaran, J. Joseph, and B. Kalyanaraman
Ceramide-induced Intracellular Oxidant Formation, Iron Signaling, and Apoptosis in Endothelial Cells: PROTECTIVE ROLE OF ENDOGENOUS NITRIC OXIDE
J. Biol. Chem.,
July 2, 2004;
279(27):
28614 - 28624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
Pharmacol. Rev.,
June 1, 2004;
56(2):
185 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shang, S. Kotamraju, S. V. Kalivendi, C. J. Hillard, and B. Kalyanaraman
1-Methyl-4-phenylpyridinium-induced Apoptosis in Cerebellar Granule Neurons Is Mediated by Transferrin Receptor Iron-dependent Depletion of Tetrahydrobiopterin and Neuronal Nitric-oxide Synthase-derived Superoxide
J. Biol. Chem.,
April 30, 2004;
279(18):
19099 - 19112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. FOGLI, P. NIERI, and M. C. BRESCHI
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage
FASEB J,
April 1, 2004;
18(6):
664 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Moura, Y. Lepelletier, B. Arnulf, P. England, C. Baude, C. Beaumont, A. Bazarbachi, M. Benhamou, R. C. Monteiro, and O. Hermine
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients
Blood,
March 1, 2004;
103(5):
1838 - 1845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Kwok and D. R. Richardson
Examination of the Mechanism(s) Involved in Doxorubicin-Mediated Iron Accumulation in Ferritin: Studies Using Metabolic Inhibitors, Protein Synthesis Inhibitors, and Lysosomotropic Agents
Mol. Pharmacol.,
January 1, 2004;
65(1):
181 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kotamraju, Y. Tampo, A. Keszler, C. R. Chitambar, J. Joseph, A. L. Haas, and B. Kalyanaraman
Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: Role of ubiquitin-proteasome pathway
PNAS,
September 16, 2003;
100(19):
10653 - 10658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Bannerman and S. E. Goldblum
Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis
Am J Physiol Lung Cell Mol Physiol,
June 1, 2003;
284(6):
L899 - L914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Kwok and D. R. Richardson
Anthracyclines Induce Accumulation of Iron in Ferritin in Myocardial and Neoplastic Cells: Inhibition of the Ferritin Iron Mobilization Pathway
Mol. Pharmacol.,
April 1, 2003;
63(4):
849 - 861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Suematsu, H. Tsutsui, J. Wen, D. Kang, M. Ikeuchi, T. Ide, S. Hayashidani, T. Shiomi, T. Kubota, N. Hamasaki, et al.
Oxidative Stress Mediates Tumor Necrosis Factor-{alpha}-Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes
Circulation,
March 18, 2003;
107(10):
1418 - 1423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tampo, S. Kotamraju, C. R. Chitambar, S. V. Kalivendi, A. Keszler, J. Joseph, and B. Kalyanaraman
Oxidative Stress-Induced Iron Signaling Is Responsible for Peroxide-Dependent Oxidation of Dichlorodihydrofluorescein in Endothelial Cells: Role of Transferrin Receptor-Dependent Iron Uptake in Apoptosis
Circ. Res.,
January 10, 2003;
92(1):
56 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Kwok and D. R. Richardson
Unexpected Anthracycline-Mediated Alterations in Iron-Regulatory Protein-RNA-Binding Activity: The Iron and Copper Complexes of Anthracyclines Decrease RNA-Binding Activity
Mol. Pharmacol.,
October 1, 2002;
62(4):
888 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|